I'm actually not clear that Trump know what Session's does

New Post Public Reply Private Reply Replies (0) Message Board
GaryM moxaman #13074
386
I'm actually not clear that Trump know what Session's does unless someone throws it in his face. Session's will clearly do anything he can to slow the industry, it's up to Congress, and/or Trump to limit or eliminate what he can do.

To me, other than legislation, nothing that is happening is permanent. The next administration could turn it around completely, and we would have to start from scratch. I cannot say if this could come in 2020, or if we could have a President Pence before than, and I'm of the belief that he might be harder on cannabis than Trump. What we really need is legislation. I'm not even certain that if the DEA changed the category for cannabis that another administration couldn't reverse that action.

We are living in a world where science is becoming less meaningful when it comes to politics. Issues like stem cells, climate change, and cannabis have evangelical factions that oppose what scientists can show is happening. It doesn't end what the scientists are doing, but it slows it, and frequently it moves leadership to countries like Israel, where science is held in high regard.

I received stem cells, but they were adult stem cells. Had placental stem cell development been permitted decades ago when they were first discovered, it may have come from the science developing around it. The difference may have been that rejection might not have been an issue at all, or perhaps they would have actually found a way to not need to kill off my entire immune system before the stem cell transplant. I certainly don't know that it would have been better had progress been allowed, but it certainly could have been. Likewise, their is no telling how much cannabis based drugs may have helped with recovery, hospitals I believe our still prevented from using them even in States where they're legal because of their classification, except if they are doing an authorized trial.

My point is that legislation is the only thing that is reasonably permanent, anything less can often be overturned by a single person who's of the other opinion, especially if that person is the President, but often by someone appointed by the President if the President doesn't intercede. If the time isn't yet right to put it into legislation, perhaps it will be in the next Congress.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 89

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 192

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
ecozy's Brezzano Switch: Brewing Simplicity at Home

Updated Category News Views 401

Breathe the aroma, sip the innovation. ecozy just threw their Brezzano Switch into the arena, and here's the deal: it's a no-nonsense, get-your-caffeine-fix kind of machine aimed at making your mornings simple without compromising on flavor. Unique Features of the Brezzano Switch So, what's cooking? Get this—it's not just any coffee contraption. Built sleek and compact,...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 184

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 174

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 347

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Adding Fireplaces: Home Comfort or Construction Headache?

Updated Category News Views 276

Sizing Up the Installation Options Slapping a fireplace into a home sounds more like a pipe dream than a practical project for most folks. But according to fireplace whiz Jimmy Smith down in North Charleston, the times are a-changin'. These days, with advances in technology, homeowners can actually pull it off without collapsing their living room walls. Nitty-Gritty:...

Continue Reading

Top 5 Most Recently Viewed Articles

Bio-Thera and Tabuk Join Forces for BAT2206 Biosimilar Launch

Updated Category News Views 136

Bio-Thera Solutions Partners with Tabuk Pharmaceuticals Bio-Thera Solutions Inc. (688177:SH) has announced a significant partnership with Tabuk Pharmaceutical Manufacturing Company, a respected player in the pharmaceutical industry. This collaboration marks a new chapter in the commercialization of BAT2206, a proposed biosimilar to Jansen's Stelara. Understanding BAT2206...

Continue Reading
Unlocking Innovative Trading Solutions with XploraDEX's $XPL

Updated Category News Views 381

XploraDEX: Transforming Trading on the XRP Ledger XploraDEX is on a mission to revolutionize the trading landscape on the XRP Ledger by implementing an intelligent, adaptive decentralized finance (DeFi) infrastructure. With the XRP ecosystem recognized for its remarkable speed and efficiency, many traders have long sought advanced solutions to fully harness its potential....

Continue Reading
Ferrari N.V. Updates on Share Buyback Program Progress

Updated Category News Views 89

Share Buyback Program at a Glance Ferrari N.V. (NYSE/EXM: RACE) has provided an update on its ongoing share buyback program. Launched in 2022 with a total budget of approximately Euro 2 billion, the program is unfolding in tranches designed to support a disciplined capital structure and steady shareholder returns. The continued rollout underscores Ferrari’s intent to...

Continue Reading
Global Ship Lease Announces Generous Dividend for Investors

Updated Category News Views 148

Global Ship Lease Declares Significant Dividend In a noteworthy announcement, Global Ship Lease, Inc. (NYSE:GSL) recently disclosed that its Board of Directors has approved a cash dividend of $0.546875 for each depositary share. Each depositary share represents a 1/100th interest in a share of the Company’s 8.75% Series B Cumulative Redeemable Perpetual Preferred...

Continue Reading
iBio Inc. Showcases Innovative Antibody Developments Soon

Updated Category News Views 194

Exciting Presentations from iBio Inc. iBio, Inc. (NASDAQ: IBIO), a pioneering biotechnology company, is gearing up to present breakthrough research on its Activin E antibody. This development showcases its commitment to addressing critical health challenges like obesity. Recently, Cory Schwartz, Ph.D., the Director of Research and Early Development at iBio, announced his...

Continue Reading